Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandro Moretta

Showing results (11-20 of 205) with videos related to

Pageof 21
Sort By:
Trends in Immunology|March 31, 2005
Cellular ligands of activating NK receptorsCristina Bottino, Roberta Castriconi, Lorenzo Moretta, et al.
Trends in Immunology|July 16, 2010
Extending killer Ig-like receptor function: from HLA class I recognition to sensors of microbial productsSimona Sivori, Michela Falco, Lorenzo Moretta, et al.
Current Protocols in Immunology|April 25, 2008
Human natural killer receptors and their ligandsRoberto Biassoni, Cristina Bottino, Claudia Cantoni, et al.
Frontiers in Immunology|October 25, 2016
Human NK Cell Subsets Redistribution in Pathological Conditions: A Role for CCR7 ReceptorSilvia Pesce, Lorenzo Moretta, Alessandro Moretta, et al.
Trends in Immunology|September 6, 2011
Origin, phenotype and function of human natural killer cells in pregnancyPaola Vacca, Lorenzo Moretta, Alessandro Moretta, et al.
Nature Immunology|September 20, 2013
Aegean reflections on innate immunityGeorge Hajishengallis, Alberto Mantovani, Alessandro Moretta, et al.
Blood|June 2, 2005
Defective killing of dendritic cells by autologous natural killer cells from acute myeloid leukemia patientsCyril Fauriat, Alessandro Moretta, Daniel Olive, et al.
Journal of Leukocyte Biology|October 11, 2013
At the Bench: Preclinical rationale for exploiting NK cells and γδ T lymphocytes for the treatment of high-risk leukemiasHåkan Norell, Alessandro Moretta, Bruno Silva-Santos, et al.
Blood|June 27, 2008
Human natural killer cells exposed to IL-2, IL-12, IL-18, or IL-4 differently modulate priming of naive T cells by monocyte-derived dendritic cellsSophie Agaugué, Emanuela Marcenaro, Bruna Ferranti, et al.
The Journal of Infectious Diseases|February 28, 2015
Role of the 2B4 Receptor in CD8+ T-Cell-Dependent Immune Control of Epstein-Barr Virus Infection in Mice With Reconstituted Human Immune System ComponentsObinna Chijioke, Emanuela Marcenaro, Alessandro Moretta, et al.
Pageof 21

Showing results (11-20 of 205) with videos related to

Sort By:
Pageof 21
Trends in Immunology|March 31, 2005
Cellular ligands of activating NK receptorsCristina Bottino, Roberta Castriconi, Lorenzo Moretta, et al.
Trends in Immunology|July 16, 2010
Extending killer Ig-like receptor function: from HLA class I recognition to sensors of microbial productsSimona Sivori, Michela Falco, Lorenzo Moretta, et al.
Current Protocols in Immunology|April 25, 2008
Human natural killer receptors and their ligandsRoberto Biassoni, Cristina Bottino, Claudia Cantoni, et al.
Frontiers in Immunology|October 25, 2016
Human NK Cell Subsets Redistribution in Pathological Conditions: A Role for CCR7 ReceptorSilvia Pesce, Lorenzo Moretta, Alessandro Moretta, et al.
Trends in Immunology|September 6, 2011
Origin, phenotype and function of human natural killer cells in pregnancyPaola Vacca, Lorenzo Moretta, Alessandro Moretta, et al.
Nature Immunology|September 20, 2013
Aegean reflections on innate immunityGeorge Hajishengallis, Alberto Mantovani, Alessandro Moretta, et al.
Blood|June 2, 2005
Defective killing of dendritic cells by autologous natural killer cells from acute myeloid leukemia patientsCyril Fauriat, Alessandro Moretta, Daniel Olive, et al.
Journal of Leukocyte Biology|October 11, 2013
At the Bench: Preclinical rationale for exploiting NK cells and γδ T lymphocytes for the treatment of high-risk leukemiasHåkan Norell, Alessandro Moretta, Bruno Silva-Santos, et al.
Blood|June 27, 2008
Human natural killer cells exposed to IL-2, IL-12, IL-18, or IL-4 differently modulate priming of naive T cells by monocyte-derived dendritic cellsSophie Agaugué, Emanuela Marcenaro, Bruna Ferranti, et al.
The Journal of Infectious Diseases|February 28, 2015
Role of the 2B4 Receptor in CD8+ T-Cell-Dependent Immune Control of Epstein-Barr Virus Infection in Mice With Reconstituted Human Immune System ComponentsObinna Chijioke, Emanuela Marcenaro, Alessandro Moretta, et al.
Pageof 21